$3.15 +0.33 (10.48%)
Metagenomi, Inc. Common Stock (MGX)
Metagenomi, Inc. (MGX) is a biotechnology company focused on the development of next-generation gene editing therapies. Leveraging its proprietary platform, the company aims to create precise, safe, and effective genetic treatment solutions for a range of genetic diseases and conditions.
Company News
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025
Metagenomi presented data at the ASGCT Annual Meeting 2025, showcasing advancements in its gene editing technologies, including compact nucleases for extrahepatic gene editing and CAST for site-specific integration of large therapeutic genes.
Stocks To Watch: Eyes On Broadcom, Target, Costco, Rivian And Small Caps
Stay informed of upcoming IPOs, earnings reports, and market events with Seeking Alpha's Stocks to Watch newsletter.
This Biotech IPO Stock Just Took a Tumble, But Don't Give Up on It Yet
A bumpy start can't detract from this company's strong balance sheet.
